Home LiteratureArticle Details
PMID: 12019079 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Resistance mechanisms in clinical isolates of Candida albicans.

Antimicrobial agents and chemotherapy ·Vol. 46 ·No. 6 ·2002-06-00 ·Pages 1704-13

White TC, Holleman S, Dy F, Mirels LF, Stevens DA

Abstract

Resistance to azole antifungals continues to be a significant problem in the common fungal pathogen Candida albicans. Many of the molecular mechanisms of resistance have been defined with matched sets of susceptible and resistant clinical isolates from the same strain. Mechanisms that have been identified include alterations in the gene encoding the target enzyme ERG11 or overexpression of efflux pump genes including CDR1, CDR2, and MDR1. In the present study, a collection of unmatched clinical isolates of C. albicans was analyzed for the known molecular mechanisms of resistance by standard methods. The collection was assembled so that approximately half of the isolates were resistant to azole drugs. Extensive cross-resistance was observed for fluconazole, clotrimazole, itraconazole, and ketoconazole. Northern blotting analyses indicated that overexpression of CDR1 and CDR2 correlates with resistance, suggesting that the two genes may be coregulated. MDR1 overexpression was observed infrequently in some resistant isolates. Overexpression of FLU1, an efflux pump gene related to MDR1, did not correlate with resistance, nor did overexpression of ERG11. Limited analysis of the ERG11 gene sequence identified several point mutations in resistant isolates; these mutations have been described previously. Two of the most common point mutations in ERG11 associated with resistance, D116E and E266D, were tested by restriction fragment length polymorphism analysis of the isolates from this collection. The results indicated that the two mutations occur frequently in different isolates of C. albicans and are not reliably associated with resistance. These analyses emphasize the diversity of mechanisms that result in a phenotype of azole resistance. They suggest that the resistance mechanisms identified in matched sets of susceptible and resistant isolates are not sufficient to explain resistance in a collection of unmatched clinical isolates and that additional mechanisms have yet to be discovered.

MeSH Terms
ATP-Binding Cassette Transporters/genetics Antifungal Agents/pharmacology Blotting, Northern Blotting, Southern Candida albicans/drug effects,genetics Candidiasis/epidemiology,microbiology DNA Probes DNA, Fungal/biosynthesis,genetics Drug Resistance, Microbial Drug Resistance, Multiple Fungal Proteins Gene Expression Regulation, Fungal/drug effects Genes, MDR/genetics Microbial Sensitivity Tests Phenotype Polymorphism, Restriction Fragment Length RNA, Fungal/biosynthesis,genetics Reverse Transcriptase Polymerase Chain Reaction
Chemicals
ATP-Binding Cassette Transporters Antifungal Agents DNA Probes DNA, Fungal FLU1 protein, Candida albicans Fungal Proteins RNA, Fungal
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
White Theodore C
Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98109-1651, USA. [email protected]
Holleman Scott
Dy Francis
Mirels Laurence F
Stevens David A
References (37)
37 references, click to expand
  1. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
    Microbiology. 1999 Oct;145 ( Pt 10):2701-13 PMID: 10537192
  2. Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans.
    J Bacteriol. 1999 Jul;181(13):4041-9 PMID: 10383973
  3. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    J Clin Microbiol. 2000 Apr;38(4):1563-8 PMID: 10747144
  4. Transcriptional analyses of antifungal drug resistance in Candida albicans.
    Antimicrob Agents Chemother. 2000 Sep;44(9):2296-303 PMID: 10952571
  5. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
    Microbiology. 2000 Nov;146 ( Pt 11):2743-54 PMID: 11065353
  6. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
    Antimicrob Agents Chemother. 2001 Oct;45(10):2676-84 PMID: 11557454
  7. Mitotic recombination in Candida albicans: recessive lethal alleles linked to a gene required for methionine biosynthesis.
    Mol Gen Genet. 1982;187(3):477-85 PMID: 6757662
  8. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli.
    Gene. 1987;57(2-3):267-72 PMID: 3319781
  9. Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.
    Nucleic Acids Res. 1989 Jan 25;17(2):804 PMID: 2644625
  10. Sequence of the Candida albicans gene encoding actin.
    Nucleic Acids Res. 1989 Nov 25;17(22):9488 PMID: 2685762
  11. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate.
    Mol Gen Genet. 1991 Jun;227(2):318-29 PMID: 2062311
  12. The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9456-9 PMID: 8415722
  13. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
    J Clin Microbiol. 1994 Jan;32(1):59-64 PMID: 7907345
  14. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Clin Infect Dis. 1994 Feb;18(2):240-2 PMID: 8161633
  15. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.
    Antimicrob Agents Chemother. 1994 Apr;38(4):648-52 PMID: 8031026
  16. High prevalence of antifungal resistance in Candida spp. from patients with AIDS.
    J Antimicrob Chemother. 1994 Nov;34(5):659-68 PMID: 7706161
  17. Multidrug resistance in Candida albicans: disruption of the BENr gene.
    Antimicrob Agents Chemother. 1995 Feb;39(2):422-6 PMID: 7726508
  18. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals.
    Curr Genet. 1995 Mar;27(4):320-9 PMID: 7614555
  19. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86 PMID: 8585712
  20. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.
    Antimicrob Agents Chemother. 1996 Feb;40(2):419-25 PMID: 8834890
  21. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Antimicrob Agents Chemother. 1997 Jan;41(1):196-9 PMID: 8980781
  22. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Microbiology. 1997 Feb;143 ( Pt 2):405-16 PMID: 9043118
  23. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
    Clin Infect Dis. 1997 Feb;24(2):235-47 PMID: 9114154
  24. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7 PMID: 9210670
  25. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans.
    Antimicrob Agents Chemother. 1997 Jul;41(7):1488-94 PMID: 9210671
  26. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains.
    FEMS Microbiol Lett. 1997 Jun 15;151(2):263-8 PMID: 9228762
  27. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
    Clin Infect Dis. 1997 Oct;25(4):908-10 PMID: 9356806
  28. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter.
    J Bacteriol. 1997 Dec;179(23):7210-8 PMID: 9393682
  29. Myelofibrosis complicated by infection due to Candida albicans: emergence of resistance to antifungal agents during therapy.
    Clin Infect Dis. 1997 Dec;25(6):1470-1 PMID: 9431398
  30. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    Oral Dis. 1997 May;3 Suppl 1:S102-9 PMID: 9456667
  31. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Antimicrob Agents Chemother. 1998 Feb;42(2):241-53 PMID: 9527767
  32. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
    Clin Microbiol Rev. 1998 Apr;11(2):382-402 PMID: 9564569
  33. A fourth gene from the Candida albicans CDR family of ABC transporters.
    Gene. 1998 Oct 5;220(1-2):91-8 PMID: 9767132
  34. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
    Antimicrob Agents Chemother. 1998 Oct;42(10):2584-9 PMID: 9756759
  35. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Antimicrob Agents Chemother. 1998 Nov;42(11):2932-7 PMID: 9797228
  36. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
    J Clin Microbiol. 1999 Feb;37(2):417-21 PMID: 9889231
  37. The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity.
    Antimicrob Agents Chemother. 2000 Jan;44(1):63-7 PMID: 10602724
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2002-06-00
Pages
1704-13
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC127245
Subset
IM
Grants
NIDCR NIH HHS · R01 DE011367 · United States
NIDCR NIH HHS · R01 DE-11367 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]